Literature DB >> 12861034

Autoreactive antibody repertoire is perturbed in atherosclerotic patients.

Giuseppina Caligiuri1, Dorothea Stahl, Srini Kaveri, Théano Irinopoulous, Françoise Savoie, Chantal Mandet, Marta Vandaele, Michel D Kazatchkine, Jean-Baptiste Michel, Antonino Nicoletti.   

Abstract

In patients with clinical symptoms of coronary atherosclerosis, T cells are activated and directed to autologous proteins contained in the active plaques, suggesting that autoimmune responses may play a role in atherosclerosis progression. Organ-specific autoimmune diseases are sometimes accompanied by broad alterations of serum autoreactive antibody repertoires. We thus investigated antibody repertoires at a global level, using a technique of immunoblotting that allows for the quantitative screening of antibody reactivities in complex antibody mixtures toward a large panel of antigens derived from homologous tissue extracts, followed by multiparametric statistical analysis of the data. We analyzed the autoreactive IgG repertoire in 20 patients with documented coronary atherosclerosis and in 20 matched healthy controls. Total proteins from atherosclerotic carotid specimens and normal arterial tissues (target organs) and from kidney, liver, and stomach (non-target control organs) were used as panels of antigens. Patients had a significantly perturbed antibody repertoire and an enhanced autoreactivity of IgG to target and non-target organs, as compared with controls. Reactivity of purified IgG to plaque and normal artery proteins was greater in patients, but reactivity of IgG in the whole serum toward normal arterial tissue was lower than in controls; this suggests that, in patients, autoreactivity toward normal arteries is regulated by serum factors. Our data indicate that atherosclerotic patients develop a perturbed humoral immune response directed toward arterial proteins, which impacts on the overall autoreactive repertoire. These findings further substantiate that autoimmune processes take place in atherosclerosis and most likely influence disease progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861034     DOI: 10.1097/01.lab.0000077010.90550.ff

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  4 in total

1.  A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.

Authors:  Giulia Fornasa; Marc Clement; Emilie Groyer; Anh-Thu Gaston; Jamila Khallou-Laschet; Marion Morvan; Kevin Guedj; Srini V Kaveri; Alain Tedgui; Jean-Baptiste Michel; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  Cardiovasc Res       Date:  2012-01-31       Impact factor: 10.787

2.  Altered spectrum of somatic hypermutation in common variable immunodeficiency disease characteristic of defective repair of mutations.

Authors:  Bhargavi Duvvuri; Venkata R S K Duvvuri; Jörg Grigull; Alberto Martin; Qiang Pan-Hammarström; Gillian E Wu; Mani Larijani
Journal:  Immunogenetics       Date:  2010-10-12       Impact factor: 2.846

3.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

Review 4.  Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More.

Authors:  Marie Le Borgne; Giuseppina Caligiuri; Antonino Nicoletti
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.